Biochemical and molecular mechanisms regulating apoptosis

Molecular and Cellular Biochemistry

Volumn 178, Issue 1-2, 1998, Pages 9-25

  Saini, Kulvinder S ^a   Walker, Neal I ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; bcl 2; c myc; Caspases; CD95 (Fas); DNA fragmentation; p53; Programmed cell death; Signal transduction

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; GROWTH FACTOR; MYC PROTEIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; CARCINOGENESIS; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; DNA DAMAGE; EUKARYOTE; GENE EXPRESSION; GENE THERAPY; GENETIC REGULATION; HUMAN; HUMAN CELL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; HUMANS; SIGNAL TRANSDUCTION;

EID: 0031887273     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006891430596     Document Type: Review

References (312)

1. Kerr JFR: Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105: 13-20, 1971
2. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972
3. Glucksmann A: Cell deaths in normal vertebrate ontogeny. Biol Rev Cambridge Philos Soc 26: 59-86, 1951
4. Clarke PGH: Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181: 195-213, 1990
5. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267-293, 1992
6. Bowen ID: Apoptosis or programmed cell death? Cell Biol Int 17: 365-380, 1993
7. Schwartz LM, Smith SW, Jones ME, Osborne BA: Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90: 980-984, 1993
8. Thompson EB: Apoptosis and steroid hormones. Mol Endocrinol 8: 665-673, 1994
9. Cohen JJ: Apoptosis. Immunol Today 14: 126-130, 1993
10. + B lymphocyte, the stage of Ig light chain gene expression. Eur J Immunol 20: 557-564, 1990
11. Ameisen JC: The origin of programmed cell death. Science 272: 1278-1279, 1996
12. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992
13. Schwarteman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14: 133-151, 1993
14. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995
15. Vaux DL, Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239-2244, 1996
16. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem 236: 1-26, 1996
17. Vogelstein B, Kinzler KW: The multi step nature of cancer. Trends Genet 9: 138-141, 1993
18. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP: Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic cell line, INS-1. Biochem Mol Biol Int 39: 1229-1236, 1996
19. Searle J, Lawson TA, Abbott PJ, Harmon BV, Kerr JFR: An electron microscopy study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol 116: 129-138, 1975
20. Dyson JED, Simmons DM, Daniel J, McLaughlin JM, Quirke P, Bird CC: Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell Tissue Kinet 19:311-324, 1986
21. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D: Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68: 3667-3673, 1994
22. Mori I, Komatsu T, Takeuchi K, Nakekuki K, Sudo M, Kimura Y: In vivo induction of apoptosis by influenza virus. J Gen Virol 76: 2869-2873, 1995
23. Ubol S, Park S, Budihardjo I, Desnoyers S, Montrose MH, Poirier GG, Kaufman SH, Griffin DE: Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during sindbis virus-induced apoptosis of neuroblastoma cells. J Virol 70: 2215-2220, 1996
24. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 76: 777-779, 1994
25. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87: 171, 1996
26. Korsmeyer SJ: Regulators of cell death. Trends Genet 11: 101-105, 1995
27. Mullbacher A, Ebnet K, Blanden RV, Hla RT, Stehle T, Museteanu C, Simon MM: Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc Natl Acad Sci USA 93: 5783-5787, 1996
28. Nagata S, Golstein P: The fas death factor. Science 267: 1449-1456, 1995
29. Fraser A, Evan G: A license to kill. Cell 85: 781-784, 1996
30. Nagata S: Apoptosis: telling cells their time is up. Curr Biol 6: 1241-1243, 1996
31. Dieken ES, Miesfield RL: Transcriptional transactivation functions localised to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol 12: 589-597, 1992
32. Collins MKL, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A: Growth factors as survival factors: regulation of apoptosis. BioEssays 16: 133-138, 1994
33. Fath I, Schweighoffer F, Rey I, Multon M-C, Boiziau J, Duchesne M, Tocque B: Cloning of a Grb2 isoform with apoptotic properties. Science 264: 971-974, 1994
34. Quan LT, Tewari M, O'Rourke K, Dixit V, Snipas SJ, Poirier GG, Ray C, Pickup DJ, Salvesan GS: Proteolytic activation of the cell death protease Yama/CPP32 by the granzyme B. Proc Natl Acad Sci USA 93: 1972-1976, 1996
35. Sanchez A, Alvarez AM, Bentio M, Fabregat I: Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J Biol Chem 271: 7416-7422, 1996
36. Nakamura N, Shidoji Y, Moriwaki H, Muto Y: Apoptosis in human hepatoma cell line induced by 4,5-didehydrogeranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-α. Biochem Biophys Res Commun 219: 100-104, 1996
37. cdc2 activation required for apoptosis. Science 263: 1143-1145, 1994
38. Sato T, Irie S, Kitada S, Reed JC: FAP-1: a protein tyrosine phosphatase that associates with fas. Science 268: 411-415, 1995
39. 2-induced apoptosis of cultured B16 melanoma cell line through down regulation of PKC activity. Biochem Biophys Res Commun 219: 480-485, 1996
40. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91: 73-77, 1994
41. Matthys P, Froyen G, Verdot L, Huang S, Sobis H, Van Damme J, Vray B, Aguet M, Billiau A: IFN-γ receptor-deficient mice are hypersensitive to the anti-CDS-induced cytokine release syndrome and thymocyte apoptosis: protective role of endogenous nitric oxide. J Immunol 155: 3823-3829, 1995
42. Novelli F, Bernabei P, Ozmen L, Rigamonti L, Allione A, Pestka S, Garotta G, Forni G: Switching on the proliferation or apoptosis of activated human T lymphocytes by IFN-γ is correlated with the differential expression of the α- and β-chains of its receptor. J Immunol 157: 1935-1943, 1996
43. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li S-H, Ross CA, Snyder SH: Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science 273: 503-507, 1996
44. Ashman RF, Peckham D, Stunz L: Fc receptor off-signal in the B cell involves apoptosis. J Immunol 157: 5-11, 1996
45. Izquirdo M, Ruiz-Ruiz MC, Lopez-Rivas A: Stimulation of phosphatidylinositol turnover is a key event for fas-dependent activation-induced apoptosis in human T lymphocytes. J Immunol 157: 21-28, 1996
46. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced fas. Diabetologia 39: 1306-1312, 1996
47. Boise LH, Thompson CB: Hierarchical control of lymphocyte survival. Science 274: 67-68, 1996
48. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of fas ligand in T-cell lineage. J Immunol 154: 3806-3813, 1995
49. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nature Med 2: 317-322, 1996
50. Suda T, Takahashi T, Golstein P, Nagata, S: Molecular cloning and expression of the fas ligand: a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993
51. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991
52. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch, DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178: 2231-2235, 1993
53. fyn T. J Biol Chem 271: 5968-5971, 1996
54. Ponton A, Clement MV, Stamenkovic I: The CD95 (APO-1/Fas) receptor activates NF-kB independently of its cytotoxic function. J Biol Chem 271: 8991-8995, 1996
55. Takahashi T, Tanaka M, Ogasawara J, Suda T, Murakami H, Nagata S: Swapping between fas and granulocyte colony-stimulating factor receptor. J Biol Chem 271: 17555-17560, 1996
56. + T cells. Proc Natl Acad Sci USA 93: 11014-11018, 1996
57. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW: CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in fas mediated apoptosis. J Biol Chem 271: 1841-1844, 1996
58. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during fas-mediated apoptosis. Nature 380: 723-726, 1996
59. Um HD, Orenstein JM, Wahl SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156: 3469-3477, 1996
60. Clement MV, Stamenkovic I: Superoxide anion is a natural inhibitor of fas-mediated cell death. EMBO J 15: 218-225, 1996
61. van den Dobbelsteen DJ, Nobel CSI, Schlegel J, Cotgreave IA, Orrenius S, Slater AFG: Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-fas/apo 1 antibody. J Biol Chem 271: 15420-15427, 1996
62. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang HG, Reed JC, Kolesnick RN, Green DR: Cell-free reconstitution of fas-, UV-radiation- and ceramide-induced apoptosis. EMBO J 14: 5191-5200, 1995
63. Enari M, Hase A, Nagata S: Apoptosis by a cytosolic extract from fas-activated cells. EMBO J 14: 5201-5208, 1995
64. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Enhanced and accelerated lymphoproliferation in fas-null mice. Proc Natl Acad Sci USA 93: 2131-2136, 1996
65. Weih F, Ryseck RP, Chen L, Bravo R: Apoptosis of nur77/N10-transgenic thymocytes involves the fas/fas ligand pathway. Proc Natl Acad Sci USA 93: 5533-5538, 1996
66. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-993, 1996
67. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995
68. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 (apo-1/fas) receptor/ligand system in drug-induced apoptosis in leukemic cells. Nature Med 2: 574-577, 1996
69. Shimizu M, Yoshimoto T, Nagata S, Matsuzawa A: A trial to kill tumor cells through Fas (CD95)-mediated apoptosis in vivo. Biochem Biophys Res Commun 228: 375-379, 1996
70. Cross M, Dexter TM: Growth factors in development, transformation, and tumorigenesis. Cell 64: 271-280, 1991
71. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB: Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA 92: 5491-5495, 1995
72. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents apoptosis in erythroid progenitor cells. Science 248:378-381, 1990
73. Williams GT, Smith CA, Spooner E, Dexter TM, Taylor DR: Haemopoitic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343: 76-79, 1990
74. Kim HRC, Upadhyay S, Li G, Palmer KC, Deuel TF: Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci USA 92: 9500-9504, 1995
75. Fox JC, Shaneley JR: Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 271: 12578-12584, 1996
76. Zou H, Niswander L: Requirement for BMP signalling in interdigital apoptosis and scale formation. Science 272: 738-741, 1996
77. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74: 823-832, 1993
78. Hartwell L: cAMPing out. Science 271: 286, 1994
79. Boe R, Gjertsen BT, Dorskeland SO, Vintermyr OK: 8-choro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer 72: 1151-1159, 1995
80. Walker NI, Bennett RE, Kerr JF: Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 185: 19-32, 1989
81. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R: Glucocorticoids and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 131: 1095-1103, 1995
82. Angel P, Karin M: The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1072: 129-157, 1991
83. Kiefer J, Orket S, Jondal M, McConkey DJ: Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line. J Immunol 155: 4525-4528, 1995
84. Helmberg A, Auphan N, Caelles C, Karin M: Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14: 452-460, 1995
85. Raff MC: Social controls on cell survival and cell death. Nature 356: 397-400, 1992
86. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995
87. Ruoslahti E, Reed JC: Anchorage dependence, integrins and apoptosis. Cell 77: 477-478, 1994
88. Meredith JE Jr, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 4: 953-961, 1993
89. 2+ channels exposed to serum from patients with type I diabetes. Science 261: 86-90, 1993
90. +-ATPase. Proc Natl Acad Sci USA 92: 5965-5968, 1995
91. Gottlieb RA, Nordberg J, Skowronski E, Babior BM: Apotosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 93: 654-658, 1996
92. Kass GEN, Ericksson JE, Weis M, Orrenius S, Chow SC: Chromatin condensation during apoptosis requires ATP. Biochem J 318: 749-752, 1996
93. Gottlieb RA, Giesing HA, Engler RL, Babior BM: The acid deoxyribonuclease of neutrophils: a possible participant in apoptosis-associated genome destruction. Blood 86: 2414-2418, 1995
94. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663-698, 1991
95. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H: Genetic control of programmed cell death in Drosophila. Science 264: 677-683, 1994
96. Luciani MF, Chimini G: The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 15: 226-235, 1996
97. Ryan KM, Birnie GD: Myc oncogenes: the enigmatic family. Biochem J 314: 713-721, 1996
98. Broussard-Diehl C, Bauer SR, Scheuermann RH: A role for c-myc in the regulation of thymocyte differentiation and possibly positive selection. J Immunol 156: 3141-3150, 1996
99. Eisenman RN, Cooper JA: Beating a path to myc. Nature 378: 438-439, 1995
100. Evan GI, Wyllie AH, Glibert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128, 1992
101. Askew DS, Ashrnun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922, 1991
102. Harrington EA, Bennett MR, Fanidi A, Evan GI: C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13: 3286-3295, 1994
103. Wu M, Arsura M, Bellas RE, Fitzgerald MJ, Lee H, Schauer SL, Sherr DH, Sonenshein GE: Inhibition of c-myc expression induces apoptosis of WEHI murine B cells. Mol Cell Biol 16: 5015-5025, 1996
104. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia AJ: Modulation of c-myc activity and apoptosis in vivo. Cancer Res 56: 4315-4319, 1996
105. Hermeking H, Eick D: Mediation of c-niyc-induced apoptosis by p53. Science 265: 2091-2093, 1994
106. Lotem J, Sachs L: A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. Proc Natl Acad Sci USA 92: 9672-9676, 1995
107. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554, 1992
108. Fanidi A, Harrington EA, Evan GI: Cooperative interactions between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556, 1992
109. Goodrich DW, Lee WH: Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature 360: 177-179, 1992
110. Levine AJ: The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177: 419-426, 1990
111. Harris CC: Chemical and physical carcinogens: advances and perspectives for the 1990s. Cancer Res 51: 5023s-5044s, 1991 (suppl)
112. Vogelstein B, Kinzler KW: Carcinogens leave fingerprints. Nature 355:209-210, 1992
113. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence specific DNA binding protein. Science 252: 1707-1711, 1991
114. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
115. Harper JW, Adami GR, Wei N, Keomarsi K, Elledge SJ: The p21 cdk-interacting protein is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
116. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interacting with PCNA. Nature 369: 574-578, 1994
117. Xiong Y, Hannon GJ, Zhang H, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993
118. Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716, 1996
119. Dowell SP, Hall PA: The p53 tumor suppressor gene and tumor prognosis: is there a relationship. J Pathol 177: 221-224, 1995
120. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379: 88-91, 1996
121. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993
122. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993
123. Elledge RM, Lee WH: Life and death by p53. BioEssays 17: 923-930, 1995
124. White E: Life, death, and the pursuit of apoptosis. Genes Dev 10: 1-15, 1996
125. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M: p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 16: 5178-5185, 1996
126. Cox LS, Lane DP: Tumor suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. BioEssays 17: 501-508, 1995
127. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991
128. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and Gadd 45 is defective in ataxiatelangiectasia. Cell 71: 587-597, 1992
129. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S: p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nature Med 2: 5577-5580, 1996
130. Brash DE: Cellular proofreading. Nature Med 2: 525-526, 1996
131. Jacks T, Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643-644, 1996
132. Lane DP: p53, guardian of the genome. Nature 358: 15-16, 1992
133. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996
134. Lane DP: p53 and human cancer. Br Med Bull 50: 582-599, 1994
135. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D: The 1993 Walter Hubert Lecture: the role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 69: 409-416, 1994
136. Gottlieb TM, Oren M: p53 in growth control and neoplasia. Biochim Biophys Acta 1287: 77-102, 1996
137. Forrester K, Ambs S, Lupond SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC: Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93: 2442-2447, 1996
138. Donehower LA, Harvey M, Slagle BL, McArther MJ, Montgomery CA Jr, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221, 1992
139. Lane DP: A death in the life of p53. Nature 362: 786-787, 1993
140. Ludwig RL, Bates S, Vousden KH: Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 16: 4952-4960, 1996
141. CIP1/WAF1 normal development but are defective in G1 checkpoint control. Cell 82: 675-684, 1995
142. Wang J, Walsh K: Resistance to apoptosis conferred by cdk inhibitor during myocyte differentiation. Science 273: 359-361, 1996
143. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 90: 8910-8914, 1993
144. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordeonez JV, Fontana JA: Mechanisms of regulation of WAF1/Cip 1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415, 1994
145. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549, 1995
146. Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, Appella E: A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270: 29386-29391, 1995
147. Gartenhaus RB, Wang P, Hoffman P: Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc Natl Acad Sci USA 93: 265-268, 1996
148. Ohnishi T, Wang X, Ohnishi K, Matsumoto H, Takahashi A: p53-dependent induction of WAF 1 by heat treatment in human glioblastoma cells. J Biol Chem 271: 14510-14513, 1996
149. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92: 5451-5455, 1995
150. Wang Y, Prives C: Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91, 1995
151. Hacker G, Vaux DL: Apoptosis: a sticky business. Curr Biol 5: 622-624, 1995
152. Hockenbery DM: Bcl-2, a novel regulator of cell death. BioEssays 17: 631-638, 1995
153. Reed JC: Balancing cell life and death: bax, apoptosis and breast cancer. J Clin Invest 97: 2403-2404, 1996
154. Oltvai ZN, Millman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619, 1993
155. Knudson CM, Tung K, Brown G, Korsmeyer SJ: Bax deficient mice with lymphoid hyperplasia and germ cell death. Science 270: 96-99, 1995
156. Kiefer MC, Brauer MJ, Powers JJ, Wu SR, Umansky LD, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed bcl-2 homologue beak. Nature 374: 736-739, 1995
157. Xiang J, Chao DT, Korsmeyer SJ: Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc Natl Acad Sci USA 93: 14559-14563, 1996
158. Hunter JJ, Parslow TG: A peptide sequence from bax that converts bcl-2 into an activator of apoptosis. J Biol Chem 271: 8521-8524, 1996
159. Zha H, Aime-Sempe C, Sato T, Reed JC: Proapoptotic protein bax heterodimerizes with bcl-2 and homodimerizes with bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 271: 7440-7444, 1996
160. Wang HG, Takayama S, Rapp UR, Reed JC: Bcl-2 interacting protein, bag-1, binds to and activates the kinase raf-1. Proc Natl Acad Sci USA 93: 7063-7068, 1996
161. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251, 1993
162. Meßmer UK, Reed JC, Brune B: Bcl-2 protects macrophages from nitric-oxide-induced apoptosis. J Biol Chem 271: 20192-20197, 1996
163. Jacobson MD, Raff MC: Programmed cell death and bcl-2 protection in very low oxygen. Nature 374: 814-816, 1995
164. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996
165. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996
166. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997
167. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng XI, Jones DP, Wang X: Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1128-1132, 1997
168. Zhang KZ, Westberg JA, Holtta E, Andersson LC: Bcl-2 regulates neural differentiation. Proc Natl Acad Sci USA 93:4504-4508, 1996
169. Borner C: Diminished cell proliferation associated with the death-protective activity of bcl-2. J Biol Chem 271: 12695-12698, 1996
170. Haldar S, Jena N, Croce CM: Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1995
171. L function upstream of the CED-3 -like apoptotic proteases. J Biol Chem 271:4573-4576, 1996
172. Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky, DS, Fritz LC, Tomaselli KJ: Fas-induced activation of the cell death-related protease CPP32 is inhibited by bcl-2 and by ICE family protease inhibitors. J Biol Chem 271: 16850-16855, 1996
173. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM: prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of bcl-2. Biochem J 316: 25-28, 1996
174. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y: Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12: 2251-2257, 1996
175. Cerretti DP, Kozlosky CJ, Mosely B, Nelson N, Ness KV, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizaro LA, Huebner K, Black RA: Molecular cloning of the interleukin-1β-converting enzyme. Science 256: 97-100, 1992
176. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin XT, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774, 1992
177. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β converting enzyme. Cell 75: 641-652, 1993
178. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 8: 1613-1626, 1994
179. Wang Z-Q, Miura L, Bergeron H, Zhu H, Yuan J: Ich-1 an ICE/Ced-3-related gene, encodes both positive and negative regulators of cell death. Cell 78: 739-750, 1994
180. Fernandes-Alnemri T, Litwack G, Alnemri E: CPP32- a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269: 30761-30764, 1994
181. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995
182. Faucheu C, Diu A, Chan AWE, Blanchet AM, Miossec C, Herve F, Collard-Dutillenl V, Gu Y, Aldape RA, Lippke JA, Rocher C, Su MSS, Livingston DJ, Hercend T, Lalanne JL: A novel human protease similar to the interleukin-1β-converting enzyme induces apoptosis in transfected cells. EMBO J 14: 1914-1922, 1995
183. Kamen J, Paskind M, Huguinin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, Mankovitch JA, Terranova M, Ghayur T: Identification and characterisation of Ich2, a novel member of the interleukin-1β-converting enzyme family of cysteine proteases. J Biol Chem 270: 15250-15256, 1995
184. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux SM, Yamin TT, Yu VL, Nicholson DW: Molecular cloning and pro-apoptotic activity of ICErel-II and ICErel-III, members of the ICE/Ced-3 family of cysteine proteases. J Biol Chem 270: 15870-15876, 1995
185. Fernandes-Alnemri T, Litwack G, Alnemri E: Mch-2, a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res 55:2737-2742, 1995
186. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Earnshaw WC, Litwack G, Alnemri ES: Mch 3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55: 6045-6052, 1995
187. Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MSS: Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J Biol Chem 271: 1825-1828, 1996
188. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93: 7464-7469, 1996
189. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW, Dixit VM: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 271: 16720-16724, 1996
190. Kumar S, Lavin MF: The ICE family of cysteine proteases as effectors of cell death. Cell Death and Differentiation 3: 255-267, 1996
191. Zhivotovsky B, Burgess DH, Orrenius S: Proteases in apoptosis. Experientia 52: 968-978, 1996
192. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesan GS, Pickup DJ: Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β-converting enzyme. Cell 69: 597-604, 1992
193. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660, 1993
194. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in fas-mediated apoptosis. Nature 375: 78-80, 1995
195. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle P, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for fas/apo-1 mediated apoptosis. Nature 375: 81-83, 1995
196. Tewari M, Dixit VM: Fas- and TNF-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270: 3255-3260, 1995
197. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MSS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000-2003, 1995
198. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfield J, Towne E, Tracey D, Wardwell S, Wei FY, Wong W, Kamen R, Seshadri T: Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-411, 1995
199. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA: Decreased apoptosis in the brain and premature lethality in CPP-32-deficient mice. Nature 384: 368-372, 1996
200. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL: Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 15: 1012-1020, 1996
201. Jacobson MD, Weil M, Raff, MC: Role of ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 133: 1041-1051, 1996
202. Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG, Borner C: Bcl-2 overexpression blocks activation of the death protease CPP32/yama/apopain. Biochem Biophys Res Commun 221: 340-345, 1996
203. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES: Molecular ordering of the fas-apoptotic pathway: the fas/apo1 protease Mch5 is a crmA-inhibitable protease that activates multiple ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93: 14486-14491, 1996
204. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES : The ced/interleukin 1β converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2 are substrates for the apoptotic mediator CPP32. J Biol Chem 271: 27099-27106, 1996
205. Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufman SH, Earnshaw WC: Cleavage of lamin A by Mch2 but not CPP32: multiple interleukin-1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93: 8395-8400, 1996
206. Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE: Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 93: 2234-2238, 1996
207. Na S, Chuang TH, Cunningham A, Turi TO, Hanke JH, Bokoch GM, Danley DE: D4-GDI, a substrate of CPP32, is proteolyzed during fas-mediated apoptosis. J Biol Chem 271: 11209-11213, 1996
208. Lazebnik YA, Kaufman SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994
209. Ding R, Smulson M: Depletion of nuclear poly(ADP-ribose) polymerase by antisense RNA expression: influences on genomic stability, chromatin organization and carcinogen cytotoxity. Cancer Res 54: 4627-4634, 1994
210. Simbulan-Rosenthal CM, Rosenthal DS, Hilz H, Hickey R, Malkas L, Applegren N, Wu Y, Bers G, Smulson ME: The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry 35: 11622-11633, 1996
211. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF: Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9: 509-520, 1995
212. Bhatia M, Kirkland JB, Meckling-Gill KA: Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells. Cell Growth Diff 7: 91-100, 1996
213. Yoon YS, Kim JW, Kang KW, Kim YS, Choi KH, Joe CO: Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J Biol Chem 271: 9129-9134, 1996
214. Kaufman SH, Desnoyers S, Ottaviano Y, Davidon NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985, 1993
215. Froelich CJ, Hanna WL, Poirier GG, Duriez PJ, D'Amours D, Salvesan GS, Alnemri ES, Earnshaw WS, Shah GM: Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly (ADP-ribose) polymerase to the 89 kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem Biophys Res Commun 227: 658-665, 1996
216. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, Raff MC: Constitutive expression of the machinery for programmed cell death. J Cell Biol 133: 1053-1059, 1996
217. Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR: Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 382: 545-547, 1996
218. Inaba T, Inukai T, Yoshihara T, Seyschab RA, Canman CE, Laken SJ, Kastan MB, Look AT: Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382: 541-544, 1996
219. Thompson CB: A fate worse than death. Nature 382: 492-493, 1996
220. Hall PA, Meek D, Lane DP: P53:integrating the complexity (editorial). J Pathol 180: 1-5, 1996
221. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, RobertsonLM, Curran T, Morgan JI: Continuous c-fos expression precedes programmed cell death in vivo. Nature 363: 166-169, 1993
222. Gajate C, Alonso MT, Schimmang T, Mollinedo F: C-fos is not essential for apoptosis. Biochem Biophys Res Commun 218: 267-272, 1996
223. Morin PJ, Vogelstein B, Kinzler KW: Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-7954, 1996
224. Nemani M, Linares-Cruz G, Bruzzoni-Giovanelli H, Roperch JP, Tuynder M, Bougueleret L, Cherif D, Medhioub M, Pasturaud P, Alvero V, Sarkissan HD, Cazes L, Le Paslier D, Le Gall I, Israeli D, Dausset J, Sigaux F, Chumakov I, Oren M, Calvo F, Amson RB, Cohen D, Telerman A: Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci USA 93: 9039-9042, 1996
225. Shimizu R, Komatsu N, Nakamura Y, Nakauchi H, Nakabeppu Y, Miura Y: Role of c-jun in the inhibition of erothropoietin receptor-mediated apoptosis. Biochem Biophys Res Commun 222: 1-6, 1996
226. Dix DJ, Allen JW, Collins BW, Mori C, Nakamura N, Poorman-Allen P, Goulding EH, Eddy EM: Targeted gene disruption of HSP70-2 results in failed meiosis, germ cell apoptosis, and male infertility. Proc Natl Acad Sci USA 93: 3264-3268, 1996
227. Blagoklonny MV, Toretsky J, Bohen S, Neckers L: Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc Natl Acad Sci USA 93: 8379-8383, 1996
228. Mehlan P, Schulze-Osthoff K, Arrigo AP: Small stress proteins as novel regulators of apoptosis: heat shock protein 27 blocks fas/apo 1 and staurosporine-induced cell death. J Biol Chem 271: 16510-16514, 1996
229. Galaktionov K, Chen X, Beach D: Cdc25 cell cycle phosphatase as a target of c-myc. Nature 382: 511-517, 1996
230. Abbadie C, Kabrun N, Bouali F, Smardova J, Stehelin D, Vandenbunder B, Enrietto PJ: High levels of c-rel are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75: 899-912, 1993
231. Cordon-Cardo C: Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560, 1995
232. Karp JE, Broder S: Molecular foundations of cancer: new targets for interventions. Nature Med 1: 309-320, 1995
233. Nigg EA: Cyclin-dependent protein kineses: key regulators of the eukaryotic cell cycle. BioEssays 17: 471-479, 1995
234. Pines J: Cyclin and cyclin-dependent kineses: a biochemical view. Biochem J 308: 697-711, 1995
235. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996
236. Owen-Lynch PJ, Wong AKY, Whetton AD: V-abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J Biol Chem 270: 5956-5962, 1995
237. Shan B, Durfee T, Lee WH: Disruption of Rb/E2F-1 interaction by single point mutation in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci USA 93: 679-684, 1996
238. White K, Tahaoglu E, Steller H: Cell killing by the drosophila gene reaper. Science 271: 805-810, 1996
239. Chen P, Lee P, Otto L, Abrams J: Apototic activity of REAPER is distinct from signalling by the tumor necrosis factor receptor 1 death domain. J Biol Chem 271: 25735-25737, 1996
240. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S, Taniguchi T: An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T-lymphocytes. Nature 376: 596-599, 1995
241. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T: Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818, 1996
242. 2-induced apoptosis of cultured B16 melanoma cell line through downregulation of PKC activity. Biochem Biophys Res Commun 219: 480-485, 1996
243. Kaipia A, Chun SY, Eisenhauer K, Hsueh AJW: Tumor necrosis factor-α and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles. Endocrinology 137: 4864-4870, 1996
244. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S: Apoptosis induction resulting from proteasome inhibition. Biochem J 317: 385-388, 1996
245. Beg AA, Baltimore D: An essential role for NF-kB in preventing TNF-alpha-induced cell death. Science 274: 782-784, 1996
246. Wang CY, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 274: 784-787, 1996
247. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-kB. Science 274: 787-789, 1996
248. Werner H, Karinieli E, Rauscher FJ, LeRoith D: Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I gene. Proc Natl Acad Sci USA 93: 8318-8323, 1996
249. Singleton JR, Randolph AK, Feldman EL: Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumori-genesis. Cancer Res 56: 4522-4529, 1996
250. Valentinis B, Baserga R: The IGF-1 receptor protects tumor cells from apoptosis induced by high concentrations of serum. Biochem Biophys Res Commun 224: 362-368, 1996
251. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL: Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93: 4974-4978, 1996
252. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980
253. Wyllie AH: Cell death. A new classification separating apoptosis from necrosis. In: D Bowen, RA Lockshin (eds). Cell Death in Biology and Pathology. London, Chapman and Hall, 1981, pp 9-34
254. Walker NI, Harmon BV, Gobé GC, Kerr JFR: Patterns of cell death. Methods Achiev Exp Pathol 13: 18-54, 1988
255. Kerr JFR, Gobé GC, Winterford CM, Harmon BV: Anatomical methods in cell death. Meth Cell Biol 46: 1-27, 1995
256. Wyllie AH: Cell death. Int Rev Cytol Suppl 17:755-785, 1987
257. Arends JA, Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32: 223-254, 1991
258. Kerr JFR, Winterford CM, Harmon BV: Morphological criteria for identifying apoptosis. In: JE Celis (ed). Cell Biology. A Laboratory Handbook. New York, Academic Press, 1994, pp 319-329
259. Russell SW, Rosenau W, Lee JC: Cytolysis induced by human lymphotoxin: cinemicrographic and electron microscopic observations. Am J Pathol 69: 103-118, 1972
260. Sanderson CJ: The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography. Proc R Soc Lond B Biol Sci 192: 241-255, 1976
261. Matter A: Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes. Immunology 36:179-190, 1979
262. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46, 1992
263. Coles HSR, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993
264. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980
265. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AK, Walker PR, Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684, 1993
266. Walker PR, Kokileva L, LeBlanc J, Sikorska M: Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques 15: 1032-1040, 1993
267. Earnshaw WC: Nuclear changes in apoptosis. Curr Opin Cell Biol 7: 337-343, 1995
268. 2+-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis. J Biol Chem 269: 14857-14860, 1994
269. Collins RJ, Harmon BV, Gobé GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61: 451-453, 1992
270. Peitsch MC, Polzar B, Stephan H, Crompton T, MacDonald HR, Mannhertz HG, Tschopp J: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 12: 371-377, 1993
271. Barry MA, Eastman A: Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 300: 440-450, 1993
272. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
273. Wijsman JH, Jonker RR, Keijzer R, Van De Velde CJH, Cornelisse CJ, Van Dierendonck JH: A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 41: 7-12, 1993
274. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21: 1465-1468, 1995
275. Ansari B, Coates PJ, Greenstein BD, Hall PA: In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170: 1-8, 1993
276. Fesus L, Thomazy V, Falus A: Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224: 104-108, 1987
277. Cummings M: Apoptosis of epithelial cells in vivo involves tissue transglutaminase upregulation. J Pathol 179: 288-293, 1996
278. Savill J, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131-136, 1993
279. Tounekti O, Belehradek J Jr, Mir LM: Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 217: 506-516, 1995
280. Telford WG, King LE, Fraker PJ: Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13: 137-143, 1992
281. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808, 1992
282. Kerr JFR, Searle J, Harmon BV, Bishop CJ: Apoptosis. In: CS Potten (ed). Perspectives on Mammalian Cell Death. Oxford: Oxford University Press, 1987, pp 93-128
283. Kerr JFR, Harmon BV: Definition and incidence of apoptosis: an historical perspective. In: LD Tomei, FO Cope (eds). Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1991, pp 5-29
284. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994
285. Cummings MC, Winterford CM, Walker NI: Apoptosis. Am J Surg Pathol 21: 88-101, 1997
286. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700, 1993
287. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CS2/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181-184, 1989
288. LO thymocytes in vivo. Science 250: 1720-1723, 1990
289. Carsetti R, Kohler G, Lamers MC: A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol 23: 168-178, 1993
290. Williamson R: Properties of rapidly labelled deoxyribonucleic acid fragments isolated from the cytoplasm of primary cultures of embryonic mouse liver cells. J Mol Biol 51: 157-168, 1970
291. Skutelsky E, Danon D: On the expulsion of the erythroid nucleus and its phagocytosis. Anat Rec 173: 123-126, 1972
292. Appleby DW, Modak SP: DNA degradation in terminally differentiating lens fiber cells from chick embryos. Proc Natl Acad Sci USA 12: 5579-5583, 1977
293. McCall CA, Cohen JJ: Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 97: 111-114, 1991
294. Hall PA, Coates PJ, Ansari B, Hopwood D: Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107: 3569-3577, 1994
295. Savill J: Macrophage recognition of senescent neutrophils. Clin Sci Colch 83: 649-655, 1992
296. Hopwood D, Levison DA: Atrophy and apoptosis in the cyclical human endometrium. J Pathol 119: 159-166, 1976
297. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
298. Wyllie AH, Kerr JFR, Currie AR: Cell death in the normal neonatal rat adrenal cortex. J Pathol 111: 255-261, 1973
299. Kerr JFR, Searle J: Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch [B] 13: 87-102, 1973
300. Walker NI: Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J Pathol 126: 439-451, 1987
301. Walker NI, Gobé GC: Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J Pathol 153: 333-344, 1987
302. Gobé GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: role of apoptosis. Lab Invest 56: 273-281, 1987
303. Allan DJ, Harmon BV: The morphologic characterization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs. Scan Electron Microsc 3: 1121-1133, 1986
304. Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12: 735-773, 1994
305. Krams SM, Egawa H, Quinn MB, Martinez OM: Apoptosis as a mechanism of cell death in a rat model of liver allograft rejection. Transplant Proc 27: 466-467, 1995
306. Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 324: 667-674, 1991
307. Patel T, Gores GJ: Apoptosis and hepatobiliary disease. Hepatology 21: 1725-1741, 1995
308. Nakanuma Y, Ohta G, Kono N, Kobayashi K, Kato Y: Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis. Liver 3: 238-248, 1983
309. Paus R, Rosenbach T, Haas N, Czarnetzki BM: Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol 2: 3-11, 1993
310. Shen Y, Shenk TE: Viruses and apoptosis. Current Opin Genet Dev 5: 105-111, 1995
311. Ameisen JC, Estaquier J, Idziorek T: From AIDS to parasite infection: pathogen mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev 142:9-51, 1994
312. Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Cuillé M-A, Béchet J-M, Montagnier L, Hovanessian AG: The cytopathic effect of HIV is associated with apoptosis. Virology 185: 829-839, 1991